| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2009-07-234823 |
| P698 | PubMed publication ID | 20089965 |
| P50 | author | Alexander Egle | Q42399958 |
| Olaf Merkel | Q55069978 | ||
| Daniela Asslaber | Q114528482 | ||
| P2093 | author name string | Richard Greil | |
| Josefina D Piñón | |||
| Petra Desch | |||
| Inge Tinhofer | |||
| Markus Stöcher | |||
| Irina Seyfried | |||
| P433 | issue | 21 | |
| P921 | main subject | chronic lymphocytic leukemia | Q1088156 |
| P304 | page(s) | 4191-4197 | |
| P577 | publication date | 2010-01-20 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia | |
| P478 | volume | 115 |
| Q35582977 | A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites |
| Q84943840 | Aberrant microRNA expression and its implications in the pathogenesis of leukemias |
| Q36022313 | Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification |
| Q28394910 | Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice |
| Q41500318 | Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. |
| Q33688416 | Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome? |
| Q26823403 | Epigenomics of leukemia: from mechanisms to therapeutic applications |
| Q39456763 | Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box. |
| Q33744997 | Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go |
| Q46689848 | Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia |
| Q34136298 | Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma |
| Q28303339 | Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia |
| Q43944556 | Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia |
| Q45960821 | Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. |
| Q30840070 | MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis |
| Q36251887 | Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach |
| Q57254485 | MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells |
| Q39411948 | MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin |
| Q43184280 | MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma |
| Q28254647 | MicroRNAs in B-cell lymphomas: how a complex biology gets more complex |
| Q82943089 | MicroRNAs in chronic lymphocytic leukemia |
| Q38797069 | MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies? |
| Q28478852 | Modeling of miRNA and drug action in the EGFR signaling pathway |
| Q38841577 | Novel mechanisms of regulation of miRNAs in CLL. |
| Q37035098 | PTCH-1 and MDM2 expression in ameloblastoma from a West African sub-population: implication for chemotherapeutics |
| Q35169579 | Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma |
| Q89458101 | Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53 |
| Q26770485 | Role of microRNAs in chemoresistance |
| Q34769735 | Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma |
| Q90274839 | Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance |
| Q36135052 | Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells |
| Q33893875 | Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL. |
| Q54271169 | Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. |
| Q26773053 | TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia |
| Q90293326 | The Nefarious Nexus of Noncoding RNAs in Cancer |
| Q38135352 | miR deregulation in CLL. |
| Q34640230 | miR-34 - a microRNA replacement therapy is headed to the clinic |
| Q38307450 | miR-34a expands myeloid-derived suppressor cells via apoptosis inhibition |
| Q92645425 | miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6 |
| Q37770977 | miRNAs in normal and malignant B cells |
Search more.